ATE484744T1 - Impfstoffe die gegen streptococcus pneumonia infektionen schützen. - Google Patents

Impfstoffe die gegen streptococcus pneumonia infektionen schützen.

Info

Publication number
ATE484744T1
ATE484744T1 AT04733500T AT04733500T ATE484744T1 AT E484744 T1 ATE484744 T1 AT E484744T1 AT 04733500 T AT04733500 T AT 04733500T AT 04733500 T AT04733500 T AT 04733500T AT E484744 T1 ATE484744 T1 AT E484744T1
Authority
AT
Austria
Prior art keywords
vaccines
relates
field
vaccine component
immunisation
Prior art date
Application number
AT04733500T
Other languages
English (en)
Inventor
Cornelis Leenhouts
Groot Ronald De
Peter Hermans
Original Assignee
Mucosis Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucosis Bv filed Critical Mucosis Bv
Application granted granted Critical
Publication of ATE484744T1 publication Critical patent/ATE484744T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT04733500T 2003-05-16 2004-05-17 Impfstoffe die gegen streptococcus pneumonia infektionen schützen. ATE484744T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03076492A EP1477802A1 (de) 2003-05-16 2003-05-16 Verfahren zur Auswahl und zum Herstellung von Impfstoffkomponenten, und deren Verwendung in Impfstoffen
PCT/NL2004/000338 WO2004102199A2 (en) 2003-05-16 2004-05-17 Method for selecting and producing vaccine components and vaccines based thereon

Publications (1)

Publication Number Publication Date
ATE484744T1 true ATE484744T1 (de) 2010-10-15

Family

ID=33016944

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04733500T ATE484744T1 (de) 2003-05-16 2004-05-17 Impfstoffe die gegen streptococcus pneumonia infektionen schützen.

Country Status (10)

Country Link
US (2) US8142789B2 (de)
EP (2) EP1477802A1 (de)
CN (1) CN100523809C (de)
AT (1) ATE484744T1 (de)
AU (1) AU2004239596B2 (de)
CA (1) CA2525766C (de)
DE (1) DE602004029565D1 (de)
DK (1) DK1625393T3 (de)
NZ (1) NZ543662A (de)
WO (1) WO2004102199A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2431315T3 (es) * 2005-05-19 2013-11-26 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Epítopos funcionales del antígeno PsaA de Streptococcus pneumoniae y usos de los mismos
AU2012201107B2 (en) * 2005-05-19 2012-11-29 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof
EP1746103A1 (de) 2005-07-20 2007-01-24 Applied NanoSystems B.V. Bifunktionelle Protein-Anker
EP1923069A1 (de) * 2006-11-20 2008-05-21 Intercell AG Schutzpeptide gegen S. pneumoniae und diesbezügliche Zusammensetzungen, Verfahren und Verwendungen
EP2343319A1 (de) 2010-01-07 2011-07-13 University of Ljubljana Genetisch modifizierter Lebensmittelgradmikroorganismus zur Behandlung der entzündlichen Darmerkrankung
RU2510281C2 (ru) 2012-06-22 2014-03-27 Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
EP3415160B1 (de) * 2014-03-04 2021-08-18 Klinikum der Universität München Aus enterococcus abgeleitete polypeptide und deren verwendung zur impfung und erstellung von therapeutischen antikörpern
CN105101456B (zh) * 2014-04-24 2019-05-07 阿尔卡特朗讯 一种用于物联网设备触发的方法、设备与系统
CN105968213A (zh) * 2016-06-14 2016-09-28 长春百克生物科技股份公司 一种肺炎链球菌融合蛋白及其疫苗
US20220241397A1 (en) * 2019-06-07 2022-08-04 Flugen, Inc. Influenza virus backbone
CN110551703A (zh) * 2019-09-10 2019-12-10 天津大学 新型材料bem的制备及应用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976542A (en) * 1996-09-23 1999-11-02 New England Medical Center Compositions and methods for treatment of streptococcus pneumoniae infection
CA2379327A1 (en) * 1999-06-10 2000-12-21 Uab Research Foundation Pneumococcal surface protein combination vaccine
EP1075841A1 (de) * 1999-08-13 2001-02-14 Erasmus Universiteit Rotterdam Pneumokokkus Impfstoffe
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
CA2450318C (en) * 2001-06-11 2011-08-02 Applied Nanosystems B.V. Improved methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms

Also Published As

Publication number Publication date
NZ543662A (en) 2009-03-31
US9549974B2 (en) 2017-01-24
WO2004102199A3 (en) 2005-02-24
EP1625393A2 (de) 2006-02-15
CA2525766C (en) 2016-06-28
DK1625393T3 (da) 2011-01-31
US20070082003A1 (en) 2007-04-12
EP1477802A1 (de) 2004-11-17
CN100523809C (zh) 2009-08-05
DE602004029565D1 (de) 2010-11-25
AU2004239596B2 (en) 2011-03-03
US8142789B2 (en) 2012-03-27
AU2004239596A1 (en) 2004-11-25
EP1625393B1 (de) 2010-10-13
CN1806172A (zh) 2006-07-19
US20120301501A1 (en) 2012-11-29
CA2525766A1 (en) 2004-11-25
WO2004102199A2 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
Holtfreter et al. Towards the immune proteome of Staphylococcus aureus–The anti-S. aureus antibody response
Shak et al. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms
Gil et al. Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection
Jost et al. Arcanobacterium pyogenes: molecular pathogenesis of an animal opportunist
AR022965A1 (es) Vacuna
ATE484744T1 (de) Impfstoffe die gegen streptococcus pneumonia infektionen schützen.
DE69941454D1 (de) Impfstoff gegen staphylokokken-vergiftung
DK1565478T3 (da) Polysaccharidvaccine mod stafylokokinfektioner
WO2006042027A8 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
WO2007030391A3 (en) Method for diagnosing infections
WO2010065735A3 (en) Methods and compositions for treating p.acnes
Waryah et al. Diversity of Virulence Factors Associated with West Australian Methicillin‐Sensitive Staphylococcus aureus Isolates of Human Origin
ATE371683T1 (de) Polarisierte gegenstände und herstellungsverfahren dafür
MX2010000864A (es) Vacuna de celulas enteras estafilococcicas inactivadas.
CY1109210T1 (el) Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια
WO2002034773A3 (en) Streptococcal genes
WO2002075507A3 (en) Anti-bacterial vaccine compositions
NO20062469L (no) Streptococcus phocae vaksine
WO2008020308A3 (en) Identification of genes implicated in the virulence of streptococcus agalactiae
WO2004098500A3 (en) CARBACEPHEM ss-LACTAM ANTIBIOTICS
WO2012122533A3 (en) Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
WO2009077744A3 (en) Vaccines for brucellosis
WO2005105845A3 (en) Phep, an amino acid permease of staphylococcus aureus
WO2004073604A3 (en) Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity
WO2011009771A3 (en) Immunogenic and therapeutic compositions for streptococcus suis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1625393

Country of ref document: EP